Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Sensor in Works Detecting Covid-19 Airborne Virus

Graphene illustration

A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air. . . . → Read More: Sensor in Works Detecting Covid-19 Airborne Virus

U.S. Supports Home Smartphone Covid-19 Test

Ellume home Covid-19 test

The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone. . . . → Read More: U.S. Supports Home Smartphone Covid-19 Test

US Govt to Buy 1.25M Regeneron Covid-19 Therapies

SARS-Cov-2 virus

The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies

BARDA Funding Vaccine Patch Clinical Trial

Nanopatch system

The U.S. government’s medical preparedness agency is funding a clinical trial of a patch that dispenses vaccines with a much lower dose than syringes. . . . → Read More: BARDA Funding Vaccine Patch Clinical Trial

Group Advancing Electronic Spinal Cord Injury Therapies

Spine

A consortium of academic and industry labs is integrating electronic sensors and neural stimulation therapies into an early treatment protocol for spinal cord injuries. . . . → Read More: Group Advancing Electronic Spinal Cord Injury Therapies

DoD Funding Variable Covid-19 Vaccine Technology

SARS-Cov-2 virus

The U.S. Department of Defense is funding work on a Covid-19 vaccine platform that can adjust its formula to protect against future mutations in the virus. . . . → Read More: DoD Funding Variable Covid-19 Vaccine Technology

NIH Issues Contracts for Faster Covid-19 Diagnostics

Accula SARS-CoV-2 test

National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays. . . . → Read More: NIH Issues Contracts for Faster Covid-19 Diagnostics

BARDA to Buy $2B in Covid-19 Vaccines, Therapies

Syringe, pills, capsules

The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials. . . . → Read More: BARDA to Buy $2B in Covid-19 Vaccines, Therapies

Fast Covid-19 Antibody Test Gets BARDA Funds

Drop of blood

A company developing point-of-care diagnostics is receiving a federal government contract for a one-drop blood test that detects Covid-19 virus antibodies in five minutes. . . . → Read More: Fast Covid-19 Antibody Test Gets BARDA Funds

Covid-19 Antibody Therapy Prepares for Trial

Cattle

A biotechnology company producing synthetic antibodies in cattle, without human blood, to treat Covid-19 infections is advancing the therapy toward a clinical trial. . . . → Read More: Covid-19 Antibody Therapy Prepares for Trial